Delivery Order SPE2DB24D8002-SPE2DB24FJMWZ
Award Date
9/9/24
Potential Completion Date
9/10/24
Potential Value
$5.3K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,071.33, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, which has an ultimate completion date of September 25, 2024. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, under the DLA Troop Support Medical's...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of 0.25 mg/0.5 mL pens of the pharmaceutical product WEGOVY. The contract has a ceiling value of $3,634.12 and a performance period ending on January 3, 2025. This contract award is part of Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which allows the company to...
This federal contract award, with ID SPE2DX15D8001|SPE2DX24FBQYK, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,791.06 firm fixed-price delivery order is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, with a completion date of May 21, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The company holds...
This is a firm fixed-price delivery order awarded by the U.S. Department of Defense's Medical Supply Chain organization (also known as the Defense Logistics Agency (DLA) Troop Support Medical) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $4,897.22 contract is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a prescription medication, with a performance period ending on April 25, 2024. The contract was awarded on...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,286.46 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products. This contract, identified as SPE2DB24D8001, is part of the DLA Troop Support Medical's ECAT Generation V Program, which enables Dakota Drug, Inc. to provide a broad range of pharmaceutical and medical supplies to support U.S. Armed Forces medical operations. The...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBQXG, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,159.86 firm fixed-price delivery order is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, with a performance period ending on May 9, 2024. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, contract number...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products. The contract has a firm fixed price pricing type, a ceiling value of $4,822.96, and a period of performance through January 7, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, holding a single-award Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $12,207.48, is for the supply of the prescription drug WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has a period of performance ending on May 21, 2024 and was awarded on May 20, 2024. This contract is not set aside for any specific business type. Dakota Drug,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The total ceiling value of the contract is $3,954.56, with a period of performance through December 18, 2023. This order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, identified as SPE2DB24D8001, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,938.23 firm fixed-price contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription pharmaceutical product. The contract has a performance period through February 12, 2024. Dakota Drug, Inc. also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...